KBC Group
WVE icon

KBC Group’s Wave Life Sciences WVE Stock Holding History

KBC Group’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24K Buy
+3,297
New +$43K ﹤0.01% 1827
2025
Q2 		– Sell
-5,440
Closed -$44K – 1822
2025
Q1 		$44K Hold
5,440
– – ﹤0.01% 1816
2024
Q4 		$67K Buy
+5,440
New +$72.6K ﹤0.01% 1757

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

KBC Group's WVE Position: Q1 2026 in Review

KBC Group opened a new position in Wave Life Sciences (WVE) in Q1 2026: 3,297 shares worth $24K. The stake represents ﹤0.01% of the portfolio and ranks #1827 among its holdings. This is a return to the name: KBC Group previously reported a position in WVE as recently as Q1 2025.

KBC Group first reported a position in WVE in Q4 2024 and has held it in 3 quarters since. The position peaked at $67K in Q4 2024. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • KBC Group held 3,297 shares of Wave Life Sciences worth $24K as of Q1 2026.
  • Wave Life Sciences was a new KBC Group position in Q1 2026.
  • Wave Life Sciences made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #1827 holding.
  • KBC Group first reported a position in Wave Life Sciences in Q4 2024 and has held it in 3 quarters since.
  • KBC Group's Wave Life Sciences position peaked at $67K in Q4 2024.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.